跳至主要内容
临床试验/CTRI/2025/11/096940
CTRI/2025/11/096940尚未招募2/3 期

A Clinical Study To Evaluate The Efficacy Of Virechana Karma And Shashanka Lekhadi Churna In The Management Of Ek Kushtha With Special Reference To Psoriasis

Government PG Ayurvedic College and Hospital,Chaukaghat, Varanasi1 个研究点 分布在 1 个国家目标入组 60 人开始时间: 2025年12月1日最近更新:

试验速览

阶段
2/3 期
状态
尚未招募
发起方
入组人数
60
试验地点
1
主要终点
Relief in Erythematous scaly plaques, Itching, Dryness

研究概览

简要总结

This study is Randomized, Parallel group study trial to evaluate the efficacy of Shashanka Lekhadi Churna and Virechana Karma in the management of Ek Kushtha(Psoriasis) Patients willbe selected randomly from OPD and iPD of Department of Kayachikitsa and Panchakarma, Government P.G. Ayurvedic College and Hospital, Varanasi.

A total no. of 60 patients will be studied under two groups having 30 patients in each group-

Group A: In this group, 30 patients will be administered with Virechana Karma

Group B: In this group, 30 patients will be administered with Shashanka Lekhadi Churna for 30 days.

Two follow ups will be done- First on 15th day of the treatment  and Second follow up on 30th day in each group.

研究设计

研究类型
Interventional
分配方式
Randomized
盲法
None

入排标准

年龄范围
18.00 Year(s) 至 60.00 Year(s)(—)
性别
All

入选标准

  • 1.Patient presenting with cardinal symptoms of Ek Kushtha i.e. Aswednam Mahavastu and Matsyashaklopamam.
  • 2.Symptoms of Psoriasis like Erythematous scaly plaques Itching Dryness.
  • 3.Patients with Immunosuppresive and Corticosteroid drugs as well as other modern medicine, if it will be tapped gradually with complete washout period of 2 weeks.
  • 4.History of Ek kushtha less than 1 year.
  • 5.Patient indicated for Virechana Karma.

排除标准

  • 1.Patient not fitting in the criteria of Virechana karma.
  • 2.Patient having history of other active Inflammatory or Rheumatic Disease Gouty Arthritis Severe Articular Inflammation.
  • 3.Patients age above 60yrs.
  • 4.Patient with severe Haematological and Hepatic, Renal disorders Tuberculosis patients of Autoimmune joint disorder or any other comorbidities.

结局指标

主要结局

Relief in Erythematous scaly plaques, Itching, Dryness

时间窗: Relief in Erythematous scaly plaques, Itching, Dryness

次要结局

未报告次要终点

研究者

发起方
Government PG Ayurvedic College and Hospital,Chaukaghat, Varanasi
申办方类型
Government medical college
责任方
Principal Investigator
主要研究者

Dr Ayush Kamboj

Government PG Ayurvedic College and Hospital, Chaukaghat, Varanasi

研究点 (1)

Loading locations...

相似试验